| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |